Heart patients, watched over wherever they are.
CardioWatch uses smart sensors and the Internet of Things to collect heart patients' data, and machine learning to classify their condition and keep them informed about their health.
Heart failure needs constant attention
Patients with acute heart failure need close follow-up, but visits are limited.
Gaps between visits
Changes in a patient's condition can go unnoticed at home.
Remote care demand
COVID-19 showed how much care must move online.
Too much data
Sensor data is only useful if it is turned into decisions.
AI-powered remote monitoring
CardioWatch joins IoT data collection with machine learning classification.
Activity tracked continuously
- Smart sensors
- Data from many sources
- Patient informed
Disease detection
- Classifies heart disease
- Higher accuracy reported
- Supports decisions
Care beyond the clinic
- Home use
- Fewer visits
- Fits telehealth
How CardioWatch works
From sensor reading to health insight.
- 1
Sense
IoT sensors collect the patient's activity and health data.
IoTSensors - 2
Transmit
Data is sent securely for storage and processing.
Cloud - 3
Classify
Machine learning models classify the patient's condition.
Machine learning - 4
Inform
Patients and carers see the health status.
DashboardAlerts
What the research showed
Findings reported in the published study.
| Function | How |
|---|---|
| Collect data | IoT smart sensors |
| Store and manage | AI-supported data handling |
| Classify disease | Machine learning models |
| Inform patients | Health status updates |
Source: Almujally et al., Sensors 23(10), 4580 (2023). doi:10.3390/s23104580
Who CardioWatch is for
For patients, carers and providers managing heart failure.
Heart failure patients
- Know your health status
- Care at home
- Peace of mind
Cardiology clinics
- Remote follow-up
- Early warning
- Better use of visits
Telehealth providers
- Ready AI + IoT design
- Scalable monitoring
- Data for decisions
Where the evidence stands
CardioWatch is a research system with experimental results.
Research system
Results come from experiments, not a clinical deployment.
Not a medical device yet
Regulatory approval would be needed before clinical use.
Validation ahead
Testing with patients in real settings is the next step.
The team
Founded in 2023 by the research team behind the study.
Turki Aljrees
Co-author of the CardioWatch research.
Nouf Abdullah Almujally
Co-author of the CardioWatch research.
Oumaima Saidani
Co-author of the CardioWatch research.
Muhammad Umer
Co-author of the CardioWatch research.
Zaid Bin Faheem
Co-author of the CardioWatch research.
Nihal Abuzinadah
Co-author of the CardioWatch research.
Khaled Alnowaiser
Co-author of the CardioWatch research.
Imran Ashraf
Co-author of the CardioWatch research.
Frequently asked questions
What does CardioWatch monitor?
The activities and health data of heart failure patients via IoT sensors.
Does it use AI?
Yes, machine learning models classify disease from the collected data.
Can doctors use it now?
Not yet. It is a research system that needs clinical validation.
Who is behind it?
Researchers including Turki Aljrees.
Peer-reviewed science behind CardioWatch.
Read the full study behind the product.
Almujally, N. A., Aljrees, T., Saidani, O., Umer, M., Faheem, Z. B., Abuzinadah, N., Alnowaiser, K., & Ashraf, I. (2023). Monitoring Acute Heart Failure Patients Using Internet-of-Things-Based Smart Monitoring System. Sensors, 23(10), 4580.
https://doi.org/10.3390/s23104580